Status:
UNKNOWN
Public Title：A Study on the Registration of The Use of Feilike HeJi in Adults
Lead Sponsor:
China Academy of Chinese Medical Sciences
Conditions:
Bronchial Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary ...
Eligibility Criteria
Inclusion
- All adult patients (age ≥18 years old) who use Feilike HeJi at the specified monitoring time and in the monitoring center (department) ;
- Must voluntarily participate in this study;
- Must meet ethical requirements.
Exclusion
- NO
Key Trial Info
Start Date :
January 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04714489
Start Date
January 16 2021
End Date
August 1 2021
Last Update
June 28 2021
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
Peking University Third Hospital Yanqing Hospital
Beijing, Beijing Municipality, China, 102100
3
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120
4
The Eighth Affiliated Hospital, Sun Yat-sen University
Shenzhen, Guangdong, China, 518033